title: A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG).
abstract: Screening and diagnostic criteria for gestational diabetes (GDM) are inconsistent across Europe, and the development of a uniform GDM screening strategy is necessary. Such a strategy would create opportunities for more women to receive timely treatment for GDM. Developing a consensus on screening for GDM in Europe is challenging, as populations are diverse and healthcare delivery systems also differ. The European Board & College of Obstetrics and Gynaecology (EBCOG) has responded to this challenge by appointing a steering committee, including members of the EBCOG and the Diabetic Pregnancy Study Group (DPSG) associated with the EASD, to develop a proposal for the use of uniform diagnostic criteria for GDM in Europe. A proposal has been developed and has now been approved by the Council of the EBCOG. The current proposal is to screen for overt diabetes at the first prenatal contact using cut-off values for diabetes outside pregnancy, with particular efforts made to screen high-risk groups. When screening for GDM is performed at 24 weeks' gestation or later, the proposal is now to use the 75 g OGTT with the new WHO diagnostic criteria for GDM. However, more research is necessary to evaluate the best GDM screening strategy for different populations in Europe. Therefore, no clear recommendation has been made on whether a universal one-step, two-step or a risk-factor-based screening approach should be used. The use of the same WHO diagnostic GDM criteria across Europe will be an important step towards uniformity.
authors.affiliation: Department of Endocrinology, UZ Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium, katrien.benhalima@uzleuven.be.
authors.forename: Katrien
authors.initials: K
authors.lastname: Benhalima
authors.forename: Chantal
authors.initials: C
authors.lastname: Mathieu
authors.forename: Peter
authors.initials: P
authors.lastname: Damm
authors.forename: André
authors.initials: A
authors.lastname: Van Assche
authors.forename: Roland
authors.initials: R
authors.lastname: Devlieger
authors.forename: Gernot
authors.initials: G
authors.lastname: Desoye
authors.forename: Rosa
authors.initials: R
authors.lastname: Corcoy
authors.forename: Tahir
authors.initials: T
authors.lastname: Mahmood
authors.forename: Jacky
authors.initials: J
authors.lastname: Nizard
authors.forename: Charles
authors.initials: C
authors.lastname: Savona-Ventura
authors.forename: Fidelma
authors.initials: F
authors.lastname: Dunne
mesh_terms: D000328:Adult; D016640:Diabetes, Gestational / Q000175:diagnosis*; D005060:Europe; D005260:Female; D018149:Glucose Intolerance / Q000175:diagnosis; D005951:Glucose Tolerance Test; D006176:Gynecology / Q000592:standards*; D006801:Humans; D008403:Mass Screening; D009774:Obstetrics / Q000592:standards*; D011247:Pregnancy; D012015:Reference Standards; D012307:Risk Factors; D014944:World Health Organization